|Bid||1.7600 x 0|
|Ask||1.7800 x 0|
|Day's Range||1.7500 - 1.8500|
|52 Week Range||0.8800 - 4.3500|
|Beta (3Y Monthly)||4.09|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.58|
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ...
Cannabis provider Liberty Health Sciences (CSE: LHS) (OTCQX: LHSIF) announced the sale of certain of its assets in Florida and substantially all of its assets in Ohio. The company is selling 36 acres of land, comprising its Chestnut Hill Tree Farm site in Alachua County, Florida, as well as all of its assets in Ohio, […]The post Cannabis Stock News Daily Roundup August 21 appeared first on Market Exclusive.
I've been keeping an eye on Khiron Life Sciences Corp. (CVE:KHRN) because I'm attracted to its fundamentals. Looking...
TORONTO, Aug. 20, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.
TORONTO, Aug. 14, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN.V - News), (OTCQB:KHRNF - News), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal ...
Four-month pilot program with EPS SURA represents first step towards an integrated healthcare system for priority neurological pathologies EPS SURA is Colombia's leading insurance provider and an affiliate ...
As the wave of positive reviews roll in, hemp-infused beauty products containing the non-psychoactive ...